# FDA 483 - Eli Lilly and Company - November 26, 2024

Source: https://www.keypedia.com/records/483/eli-lilly-and-company/7d8c5b19-5820-4d6d-bf4a-be654f05b00e

> FDA 483 for Eli Lilly and Company on November 26, 2024. Product: device. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Eli Lilly and Company
- Inspection Date: 2024-11-26
- Product Type: device
- Office Name: Atlanta District Office
- Summary: An FDA inspection of Eli Lilly and Company in Concord, NC, revealed an issue with equipment design related to drug product storage. Specifically, the firm's temperature mapping verification for semi-finished syringes was found to be inadequate because the load pattern simulation did not accurately represent a full load. This indicates a deficiency in ensuring appropriate storage conditions for drug products.

## Related Officers

- [Jocelyn C. Turner](https://www.keypedia.com/people/jocelyn-c-turner/7e39f6e0-9750-4460-8a4e-27ee9306b77e)
- [Investigator](https://www.keypedia.com/people/sonya-m-edmonds/a38fad3f-f664-4c52-8e50-78782f56ff18)

Company: https://www.keypedia.com/companies/eli-lilly-and-company/3ee60880-ca28-4c3e-a630-512617af2daa

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7